A Vancouver-based clinical-stage biotechnology company that combines single-cell screening, microfluidics and AI to discover and develop antibody therapeutics across oncology and immunology, while holding downstream stakes in 40 partner-led programs.
A Vancouver-based clinical-stage biotechnology company that combines single-cell screening, microfluidics and AI to discover and develop antibody therapeutics across oncology and immunology, while holding downstream stakes in 40 partner-led programs.
